Basic Stats
| LEI | 254900U6E39J1MQCCY14 |
| CIK | 1287865 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Medical Properties Trust, Inc.
SEC Filings (Chronological Order)
This page provides a complete, chronological list of SEC Filings, excluding ownership filings which we provide elsewhere.
| August 14, 2025 |
EX-1.1 Exhibit 1.1 MEDICAL PROPERTIES TRUST, INC. $500,000,000 Shares of Common Stock (par value $0.001 per share) EQUITY DISTRIBUTION AGREEMENT August 11, 2025 Truist Securities, Inc. Truist Securities, Inc. Truist Bank Barclays Capital Inc. Barclays Capital Inc. Barclays Bank PLC BNP Paribas Securities Corp. BNP Paribas Securities Corp. BNP PARIBAS BofA Securities, Inc. BofA Securities, Inc. Ban |
|
| August 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 11, 2025 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in its Charter) Maryland Delaware 001-32559 333-177186 20-0191742 |
|
| August 11, 2025 |
Calculation of Filing Fee Tables S-3 MEDICAL PROPERTIES TRUST INC Table 1: Newly Registered and Carry Forward Securities ☐Not Applicable Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forward Form Type Carry Forward File Number Carry Forward Initial Effective Date Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward Newly Registered Securities Fees to be Paid 1 Equity Common Stock, $0. |
|
| August 11, 2025 |
424B5 Filed Pursuant to Rule 424(b)(5) Registration No. 333-287726 PROSPECTUS SUPPLEMENT (To Prospectus dated June 2, 2025) $500,000,000 Common Stock We have entered into an equity distribution agreement for a continuous offering program with Truist Securities, Inc., Barclays Capital Inc., BNP Paribas Securities Corp., BofA Securities, Inc., Citizens JMP Securities, LLC, Credit Agricole Securities |
|
| August 11, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 11, 2025 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Commission File Numb |
|
| August 11, 2025 |
U.S. FEDERAL INCOME TAX CONSIDERATIONS EX-99.1 Exhibit 99.1 U.S. FEDERAL INCOME TAX CONSIDERATIONS This section summarizes the current material federal income tax consequences to Medical Properties and the Operating Partnership generally resulting from the treatment of Medical Properties as a REIT. Because this section is a general summary, it does not address all of the potential tax issues that may be relevant to you in light of your |
|
| August 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file number |
|
| July 31, 2025 |
Exhibit 99.1 Contact: Drew Babin, CFA, CMA Head of Financial Strategy and Investor Relations Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST, INC. REPORTS SECOND QUARTER RESULTS AND UPDATE Rapid Growth in Cash Rents from New Operators Recent Transactions Continue to Validate Asset Values and Provide Balance Sheet Flexibility Birmingham, AL – |
|
| July 31, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 31, 2025 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of in |
|
| July 31, 2025 |
QUARTERLY SUPPLEMENTAL 2Q 2025 AT T H E V E R Y H E A R T O F H E A LT H C A R E .® EX-99.2 QUARTERLY SUPPLEMENTAL 2Q 2025 AT T H E V E R Y H E A R T O F H E A LT H C A R E .® Exhibit 99.2 COMPANY OVERVIEW FORWARD-LOOKING STATEMENTS 3 This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section Company Information 3 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements |
|
| June 3, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 29, 2025 MEDICAL PROPERTIES TRUST, INC. (Exact name of Registrant as Specified in Its Charter) Maryland 001-32559 20-0191742 (State or Other Jurisdiction of Incorporation) (Commis |
|
| June 2, 2025 |
As filed with the Securities and Exchange Commission on June 2, 2025 Table of Contents As filed with the Securities and Exchange Commission on June 2, 2025 Registration No. |
|
| June 2, 2025 |
Calculation of Filing Fee Table Exhibit 107 Calculation of Filing Fee Table Form S-3 (Form Type) Medical Properties Trust, Inc. |
|
| June 2, 2025 |
Statement of Eligibility on Form T-1 Exhibit 25.1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 ☐ Check if an Application to Determine Eligibility of a Trustee Pursuant to Section 305(b)(2) WILMINGTON TRUST, NATIONAL ASSOCIATION (Exact name of trustee as specified in its charter) 16-1486454 (I.R.S. employer identification no.) 1100 North Market Street Wilmington, DE 19890-0001 (Address of principal |
|
| May 20, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for |
|
| May 9, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file numbe |
|
| May 1, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 1, 2025 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of inco |
|
| May 1, 2025 |
Exhibit 99.1 Contact: Drew Babin, CFA, CMA Head of Financial Strategy and Investor Relations Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST, INC. REPORTS FIRST QUARTER RESULTS Results Consistent with Expectations Following Mid-Quarter Debt Refinancing Birmingham, AL – May 1, 2025 – Medical Properties Trust, Inc. (the “Company” or “MPT”) (NY |
|
| May 1, 2025 |
QUARTERLY SUPPLEMENTAL 1Q 2025 AT T H E V E R Y H E A R T O F H E A LT H C A R E .® Exhibit 99.2 QUARTERLY SUPPLEMENTAL 1Q 2025 AT T H E V E R Y H E A R T O F H E A LT H C A R E .® COMPANY OVERVIEW FORWARD-LOOKING STATEMENTS 3 This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section Company Information 3 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements can gene |
|
| April 17, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of |
|
| April 17, 2025 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confid |
|
| March 3, 2025 |
Subsidiaries of Medical Properties Trust, Inc. Exhibit 21.1 SUBSIDIARIES OF REGISTRANT Subsidiaries Jurisdiction of Organization Jurisdiction(s) in Which Qualified as a Foreign Corporation Medical Properties Trust, LLC Delaware Alabama, Massachusetts Mountain View-MPT Hospital, LLC Delaware Idaho MPT of Altoona, LLC Delaware Wisconsin MPT of Alvin FCER, LLC Delaware Texas MPT Bath S.a.r.l. Luxembourg — MPT of Bayonne, LLC Delaware New Jersey M |
|
| March 3, 2025 |
Exhibit 4.11 Twentieth Supplemental Indenture (this “Supplemental Indenture”), dated as of February 28, 2025, among MPT Springstone REIT, Inc. (the “Guaranteeing Subsidiary”), a subsidiary of MPT Operating Partnership L.P., a Delaware limited partnership (“Opco”), Opco, MPT Finance Corporation (“Finco” and, together with Opco, the “Issuers”), Medical Properties Trust, Inc., a Maryland corporation |
|
| March 3, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file |
|
| February 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 27, 2025 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction o |
|
| February 27, 2025 |
EX-99.1 Exhibit 99.1 Contact: Drew Babin, CFA, CMA Head of Financial Strategy and Investor Relations Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST, INC. REPORTS FOURTH QUARTER AND FULL-YEAR RESULTS Completed Approximately $5.5 Billion of Asset Monetization Transactions, Including February’s $2.5 Billion Senior Secured Notes Offering That A |
|
| February 27, 2025 |
EX-99.2 Exhibit 99.2 Exhibit 99.2 QUARTERLY SUPPLEMENTAL4Q 2024 3 COMPANY OVERVIEWCompany Information 3FINANCIAL INFORMATION6 Reconciliation of Funds from Operations 6 Debt Summary 7 Debt Maturities and Debt Metrics 8PORTFOLIO INFORMATION Lease and Loan Maturity Schedule 99 Total Assets and Revenues by Asset Type, Operator, State and Country 10 Rent Coverage 13 Summary of Acquisitions, Active Deve |
|
| February 18, 2025 |
Exhibit 4.1 INDENTURE Dated as of February 13, 2025 Among MPT OPERATING PARTNERSHIP, L.P. and MPT FINANCE CORPORATION, as the Issuers, and MEDICAL PROPERTIES TRUST, INC., as Parent and a Guarantor, and SUBSIDIARIES PARTY HERETO, as Subsidiary Guarantors, and WILMINGTON TRUST, NATIONAL ASSOCIATION, as Trustee, Dollar Paying Agent, Dollar Registrar, Dollar Transfer Agent and Notes Collateral Agent, |
|
| February 18, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 13, 2025 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Commission File Nu |
|
| February 18, 2025 |
Exhibit 10.1 AMENDMENT NO. 3 TO SECOND AMENDED AND RESTATED REVOLVING CREDIT AND TERM LOAN AGREEMENT This AMENDMENT NO. 3 TO SECOND AMENDED AND RESTATED REVOLVING CREDIT AND TERM LOAN AGREEMENT, dated as of February 13, 2025 (this “Amendment No. 3”), is by and among MEDICAL PROPERTIES TRUST, INC., a Maryland corporation (“Holdings”), MPT OPERATING PARTNERSHIP, L.P., a Delaware limited partnership |
|
| January 31, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 30, 2025 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Commission File Num |
|
| January 31, 2025 |
EX-99.1 Exhibit 99.1 Contact: Drew Babin, CFA, CMA Head of Financial Strategy and Investor Relations Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST ANNOUNCES PRICING OF $1.5 BILLION 8.500% SENIOR SECURED NOTES DUE 2032 AND €1.0 BILLION 7.000% SENIOR SECURED NOTES DUE 2032 Pricing Represents a Blended Coupon of 7.885% Birmingham, AL – Januar |
|
| January 29, 2025 |
EX-99.1 Exhibit 99.1 Recent Developments Disposition and Recovery Transactions During the year ended December 31, 2024, we strategically disposed of properties and received insurance proceeds aggregating approximately $2.0 billion, as further detailed below, and realized net real estate gains of approximately $570 million. On April 9, 2024, we completed the sale of five properties to Prime Healthc |
|
| January 29, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 29, 2025 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Commission File Num |
|
| January 29, 2025 |
EX-99.2 Exhibit 99.2 Contact: Drew Babin, CFA, CMA Head of Financial Strategy and Investor Relations Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST ANNOUNCES PRIVATE OFFERING OF SENIOR SECURED NOTES Birmingham, AL – January 29, 2025 – Medical Properties Trust, Inc. (the “Company” or “MPT”) (NYSE: MPW) today announced that its operating part |
|
| November 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A (Amendment No.1) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A (Amendment No.1) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-3255 |
|
| November 13, 2024 |
Exhibit 10.1 AMENDMENT NO. 2 TO SECOND AMENDED AND RESTATED REVOLVING CREDIT AND TERM LOAN AGREEMENT This AMENDMENT NO. 2 TO SECOND AMENDED AND RESTATED REVOLVING CREDIT AND TERM LOAN AGREEMENT, dated as of August 6, 2024 (this “Amendment No. 2”), is by and among MEDICAL PROPERTIES TRUST, INC., a Maryland corporation (“Holdings”), MPT OPERATING PARTNERSHIP, L.P., a Delaware limited partnership (th |
|
| November 12, 2024 |
Exhibit 10.1 AMENDMENT NO. 2 TO SECOND AMENDED AND RESTATED REVOLVING CREDIT AND TERM LOAN AGREEMENT This AMENDMENT NO. 2 TO SECOND AMENDED AND RESTATED REVOLVING CREDIT AND TERM LOAN AGREEMENT, dated as of August 6, 2024 (this “Amendment No. 2”), is by and among MEDICAL PROPERTIES TRUST, INC., a Maryland corporation (“Holdings”), MPT OPERATING PARTNERSHIP, L.P., a Delaware limited partnership (th |
|
| November 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file n |
|
| November 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 7, 2024 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of |
|
| November 7, 2024 |
Medical Properties Trust QUARTERLY SUPPLEMENTAL 3Q 2024 Exhibit 99.2 Medical Properties Trust QUARTERLY SUPPLEMENTAL 3Q 2024 3 COMPANY OVERVIEW Company Information 3 FINANCIAL INFORMATION 6 Reconciliation of Funds from Operations 6 Debt Summary 7 Debt Maturities and Debt Metrics 8 PORTFOLIO INFORMATION Lease and Loan Maturity Schedule 9 9 Total Assets and Revenues by Asset Type, Operator, State and Country 10 Rent Coverage 13 Summary of Investments and |
|
| November 7, 2024 |
EX-99.1 Exhibit 99.1 Contact: Drew Babin, CFA, CMA Head of Financial Strategy and Investor Relations Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST, INC. REPORTS THIRD QUARTER RESULTS Operations of 17 Former Steward Hospitals Transitioned to Five New Operators Approximately $2.9 Billion of Year-to-Date Liquidity Transactions Completed Birmi |
|
| September 17, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 11, 2024 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Commission File N |
|
| August 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file number |
|
| August 9, 2024 |
Exhibit 10.1 AMENDMENT NO. 1 TO SECOND AMENDED AND RESTATED REVOLVING CREDIT AND TERM LOAN AGREEMENT This AMENDMENT NO. 1 TO SECOND AMENDED AND RESTATED REVOLVING CREDIT AND TERM LOAN AGREEMENT, dated as of April 12, 2024 (this “Amendment No. 1”), is by and among MEDICAL PROPERTIES TRUST, INC., a Maryland corporation (“Holdings”), MPT OPERATING PARTNERSHIP, L.P., a Delaware limited partnership (th |
|
| August 8, 2024 |
QUARTERLY SUPPLEMENTAL 2Q 2024 EX-99.2 Exhibit 99.2 QUARTERLY SUPPLEMENTAL 2Q 2024 Pictured above: Klinik am Burggraben—Bad Salzuflen, Germany—Operated by MEDIAN. On the cover: Málaga Center of Excellence—Málaga, Spain—Operated by GenesisCare. FORWARD-LOOKING STATEMENTS This press release includes forward-looking statements within the meaning COMPANY OVERVIEW of Section 27A of the Securities Act of 1933, as amended, and Section |
|
| August 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 8, 2024 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Commission File Numbe |
|
| August 8, 2024 |
Exhibit 99.1 Contact: Drew Babin, CFA, CMA Head of Financial Strategy and Investor Relations Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST, INC. REPORTS SECOND QUARTER RESULTS Successfully Executed More than $2.5 Billion in Year-to-Date Liquidity Transactions Modified Credit Facility Terms and Conditions Birmingham, AL – August 8, 2024 – M |
|
| June 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 30, 2024 MEDICAL PROPERTIES TRUST, INC. (Exact name of Registrant as Specified in Its Charter) Maryland 001-32559 20-0191742 (State or Other Jurisdiction of Incorporation) (Commis |
|
| May 29, 2024 |
Exhibit 10.2 AMENDMENT TO SECOND AMENDED AND RESTATED MASTER LEASE AGREEMENT (2024 Bridge Loan and Second Forbearance Agreement) THIS AMENDMENT TO SECOND AMENDED AND RESTATED MASTER LEASE AGREEMENT (this “Amendment”), dated February 21, 2024, is by and among certain Affiliates of MPT OPERATING PARTNERSHIP, L.P., a Delaware limited partnership (“MPT”), as further described on the signature pages he |
|
| May 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 9, 2024 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Maryland 001-32559 20-0191742 (State or other jurisdiction of incorpo |
|
| May 29, 2024 |
Exhibit 10.1 AMENDMENT TO SECOND AMENDED AND RESTATED MASTER LEASE AGREEMENT (Stewardship Note) THIS AMENDMENT TO SECOND AMENDED AND RESTATED MASTER LEASE AGREEMENT (this “Amendment”), dated January 2, 2024, is by and among certain Affiliates of MPT OPERATING PARTNERSHIP, L.P., a Delaware limited partnership (“MPT”), as further described on the signature pages hereto (collectively, jointly and sev |
|
| May 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file numbe |
|
| May 29, 2024 |
QUARTERLY SUPPLEMENTAL 1Q 2024 (UPDATED) EX-99.1 Exhibit 99.1 QUARTERLY SUPPLEMENTAL 1Q 2024 (UPDATED) No Spacing;MEDICAL PROPERTIES TRUST | SUPPLEMENTAL INFORMATION | Q1 2024 2 COMPANY OVERVIEW Company Information 3 FINANCIAL INFORMATION Reconciliation of Funds from Operations 6 Debt Summary 7 Debt Maturities and Debt Metrics 8 PORTFOLIO INFORMATION Lease and Loan Maturity Schedule 9 Total Assets and Revenues by Asset Type, Operator, St |
|
| May 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 21, 2024 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Commission File Number |
|
| May 22, 2024 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidenti |
|
| May 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 16, 2024 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Commission File Number |
|
| May 16, 2024 |
MEDICAL PROPERTIES TRUST COMMENTS ON DELAYED FORM 10-Q FILING AND RELATED NOTICE FROM NYSE Exhibit 99.1 Contact: Drew Babin, CFA, CMA Senior Managing Director of Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST COMMENTS ON DELAYED FORM 10-Q FILING AND RELATED NOTICE FROM NYSE Birmingham, AL – May 16, 2024 – As described in the Form 12b-25 previously filed by Medical Properties Trust, Inc. (the “Company” or |
|
| May 13, 2024 |
SEC File Numbers: 001-32559, 333-177186 CUSIP Number: 58463J304 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 6, 2024 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 Dela |
|
| May 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 9, 2024 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of inco |
|
| May 9, 2024 |
EX-99.1 Exhibit 99.1 Contact: Drew Babin, CFA, CMA Senior Managing Director of Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST, INC. REPORTS FIRST QUARTER RESULTS Executed Total Liquidity Transactions of $1.6 Billion Year-to-Date, or 80% of MPT’s Initial FY 2024 Target Debt, Net of Cash, Reduced by Approximately $1.6 |
|
| May 9, 2024 |
EX-99.2 Exhibit 99.2 Medical Properties Trust QUARTERLY SUPPLEMENTAL 1Q 2024 COMPANY OVERVIEW Company Information 3 FINANCIAL INFORMATION 6 Reconciliation of Funds from Operations 6 Debt Summary 7 Debt Maturities and Debt Metrics 8 PORTFOLIO INFORMATION Lease and Loan Maturity Schedule 9 9 Total Assets and Revenues by Asset Type, Operator, State and Country 10 Rent Coverage 13 Summary of Invest |
|
| May 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 6, 2024 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Maryland 001-32559 20-0191742 Delaware 333-177186 20-0242 |
|
| April 18, 2024 |
EX-99.1 Exhibit 99.1 Contact: Drew Babin, CFA, CMA Senior Managing Director of Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST SELLS MAJORITY INTEREST IN UTAH HOSPITALS Generates Approximately $1.1 Billion of Total Cash Proceeds to MPT Brings Total Liquidity Transactions Year-to-Date to $1.6 Billion, or 80% of MPT’ |
|
| April 18, 2024 |
EX-99.2 Exhibit 99.2 MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES MPT OPERATING PARTNERSHIP, L.P. AND SUBSIDIARIES UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL INFORMATION Joint Venture Transaction These unaudited pro forma condensed consolidated financial statements of Medical Properties Trust, Inc. and subsidiaries, and of MPT Operating Partnership, L.P. and subsidiaries have been pre |
|
| April 18, 2024 |
Regulation FD Disclosure, Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 12, 2024 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Commission File Numbe |
|
| April 17, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for |
|
| April 17, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ |
|
| March 14, 2024 |
Form of Award Agreement for Restricted Stock Units EX-10.1 Exhibit 10.1 MEDICAL PROPERTIES TRUST, INC. AMENDED AND RESTATED 2019 EQUITY INCENTIVE PLAN AWARD AGREEMENT FOR CASH-SETTLED RESTRICTED STOCK UNITS THIS AWARD AGREEMENT (the “Agreement”) is made effective and entered into with an award grant date as of March 8, 2024 (the “Grant Date”) by and between MEDICAL PROPERTIES TRUST, INC., a Maryland corporation (the “Company”), and (the “Participa |
|
| March 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 8, 2024 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of in |
|
| February 29, 2024 |
Subsidiaries of Medical Properties Trust, Inc. Exhibit 21.1 SUBSIDIARIES OF REGISTRANT Subsidiaries Jurisdiction of Organization Jurisdiction(s) in Which Qualified as a Foreign Corporation Medical Properties Trust, LLC Delaware Alabama, Massachusetts Mountain View-MPT Hospital, LLC Delaware Idaho MPT of Altoona, LLC Delaware Wisconsin MPT of Alvin FCER, LLC Delaware Texas MPT Bath S.a.r.l. Luxembourg — MPT of Bayonne, LLC Delaware New Jersey M |
|
| February 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file |
|
| February 29, 2024 |
Exhibit 19.2 MEDICAL PROPERTIES TRUST, INC. Insider Trading Policy Revised August 18, 2016 Important: Any director or employee who wishes to trade in the Company's securities must contact the Chief Financial Officer (the "CFO ") for approval prior to making such trade. Background Federal securities laws prohibit (i) buying or selling a company's securities by anyone who is aware of material nonpub |
|
| February 29, 2024 |
Exhibit 19.1 MEDICAL PROPERTIES TRUST, INC. COMPENSATION RECOVERY POLICY Adopted as of November 9, 2023 Medical Properties Trust, Inc., a Maryland corporation (the “Company”), has adopted a Compensation Recovery Policy (this “Policy”) as described below. This Policy supersedes and replaces the Company’s Clawback Policy adopted in 2013 (the “Prior Policy”) with respect to Incentive-Based Compensati |
|
| February 21, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 21, 2024 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction o |
|
| February 21, 2024 |
EX-99.1 Exhibit 99.1 Contact: Drew Babin, CFA, CMA Senior Managing Director of Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST, INC. REPORTS FOURTH QUARTER AND FULL-YEAR RESULTS Accelerated Asset Divestiture Strategy with More Than $480 million of Liquidity Transactions Birmingham, AL – February 21, 2024 – Medical Pr |
|
| February 21, 2024 |
QUARTERLY SUPPLEMENTAL FOURTH QUARTER 2023 EX-99.2 Exhibit 99.2 QUARTERLY SUPPLEMENTAL FOURTH QUARTER 2023 3 COMPANY OVERVIEW Company Information 3 FINANCIAL INFORMATION 6 Reconciliation of Funds from Operations 6 Debt Summary 7 Debt Maturities and Debt Metrics 8 PORTFOLIO INFORMATION Lease and Loan Maturity Schedule 9 9 Total Assets and Revenues by Asset Type, Operator, State and Country 10 Rent Coverage 13 Summary of Investments and Deve |
|
| February 13, 2024 |
MPW / Medical Properties Trust, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 18)* Name of issuer: Medical Properties Trust Inc Title of Class of Securities: Common Stock CUSIP Number: 58463J304 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate the rule pursuant to which this Schedule i |
|
| February 8, 2024 |
February 8, 2024 VIA EDGAR United States Securities and Exchange Commission Division of Corporate Finance Office of Real Estate and Construction 100 F Street, NE Washington, D. |
|
| January 24, 2024 |
January 24, 2024 VIA EDGAR United States Securities and Exchange Commission Division of Corporate Finance Office of Real Estate and Construction 100 F Street, NE Washington, D. |
|
| January 5, 2024 |
MEDICAL PROPERTIES TRUST PROVIDES UPDATE ON STEWARD HEALTH CARE EX-99.1 Exhibit 99.1 Contact: Drew Babin, CFA, CMA Senior Managing Director of Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST PROVIDES UPDATE ON STEWARD HEALTH CARE Birmingham, AL – January 4, 2024 – Medical Properties Trust, Inc. (the “Company” or “MPT”) (NYSE: MPW) today announced plans to accelerate its efforts t |
|
| January 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 2, 2024 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Commission File Numb |
|
| December 14, 2023 |
Form of Award Agreement for Restricted Stock*** EX-10.1 Exhibit 10.1 MEDICAL PROPERTIES TRUST, INC. AMENDED AND RESTATED 2019 EQUITY INCENTIVE PLAN AWARD AGREEMENT FOR RESTRICTED STOCK THIS AWARD AGREEMENT (the “Agreement”) is made effective and entered into with an award grant date as of December , 2023 (the “Grant Date”) by and between MEDICAL PROPERTIES TRUST, INC., a Maryland corporation (the “Company”), and (the “Participant”) pursuant to |
|
| December 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 8, 2023 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of |
|
| November 21, 2023 |
November 21, 2023 VIA EDGAR United States Securities and Exchange Commission Division of Corporate Finance Office of Real Estate and Construction 100 F Street, NE Washington, D. |
|
| November 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file n |
|
| October 26, 2023 |
Medical Properties Trust QUARTERLY SUPPLEMENTAL THIRD QUARTER 2023 EX-99.2 Exhibit 99.2 Medical Properties Trust QUARTERLY SUPPLEMENTAL THIRD QUARTER 2023 THIRD QUARTER 2023 COMPANY OVERVIEW Company Information 3 FINANCIAL INFORMATION Reconciliation of Net Income to Funds from Operations 6 Debt Summary 7 Debt Maturities and Debt Metrics 8 PORTFOLIO INFORMATION Lease and Loan Maturity Schedule 9 Total Assets and Revenues by Asset Type, Operator, State and Country |
|
| October 26, 2023 |
EX-99.1 Exhibit 99.1 Contact: Drew Babin, CFA, CMA Senior Managing Director of Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST, INC. CONFIRMS LONG-TERM STRENGTH, STABILITY AND PERFORMANCE OF BUSINESS MODEL IN THIRD QUARTER RESULTS Per Share Net Income of $0.19 and Normalized FFO of $0.38 in Third Quarter Expected Liq |
|
| October 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 26, 2023 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of |
|
| August 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file number |
|
| August 8, 2023 |
EX-99.1 Exhibit 99.1 Contact: Drew Babin, CFA, CMA Senior Managing Director of Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST, INC. REPORTS SECOND QUARTER RESULTS Per Share Net Loss of ($0.07) and Normalized FFO of $0.48 in Second Quarter Birmingham, AL – August 8, 2023 – Medical Properties Trust, Inc. (the “Company |
|
| August 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 8, 2023 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of i |
|
| August 8, 2023 |
MPT Medical Properties Trust QUARTERLY SUPPLEMENTAL SECOND QUARTER 2023 EX-99.2 Exhibit 99.2 MPT Medical Properties Trust QUARTERLY SUPPLEMENTAL SECOND QUARTER 2023 3 COMPANY OVERVIEW Company Information 3 FINANCIAL INFORMATION 6 Reconciliation of Net Income to Funds from Operations 6 Debt Summary 7 Debt Maturities and Debt Metrics 8 PORTFOLIO INFORMATION Lease and Loan Maturity Schedule 9 9 Total Assets and Revenues by Asset Type, Operator, State and Country 10 Rent |
|
| July 18, 2023 |
July 18, 2023 VIA EDGAR United States Securities and Exchange Commission Division of Corporate Finance Office of Real Estate and Construction 100 F Street, NE Washington, D. |
|
| May 26, 2023 |
Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 25, 2023 MEDICAL PROPERTIES TRUST, INC. (Exact name of Registrant as Specified in Its Charter) Maryland 001-32559 20-0191742 (State or Other Jurisdiction of Incorporation) (Commis |
|
| May 25, 2023 |
EX-99.1 Exhibit 99.1 Contact: Drew Babin, CFA, CMA Senior Managing Director – Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST ANNOUNCES PROSPECT RECAPITALIZATION TRANSACTIONS Third-Party Lenders Invest $375 Million in Prospect Proceeds Fully Repay Prospect’s ABL Facility Birmingham, AL – May 23, 2023 – Medical Proper |
|
| May 25, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 23, 2023 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Commission File Number |
|
| May 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file numbe |
|
| April 27, 2023 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, fo |
|
| April 27, 2023 |
EX-99.1 Exhibit 99.1 Contact: Drew Babin, CFA, CMA Senior Managing Director of Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST, INC. REPORTS FIRST QUARTER RESULTS Per Share Net Income of $0.05 and Normalized FFO of $0.37 in First Quarter Recent Transactions Validate Underwritten Values; Provides Additional Capital Fl |
|
| April 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 27, 2023 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of i |
|
| April 27, 2023 |
QUARTERLY SUPPLEMENTAL FIRST QUARTER 2023 EX-99.2 Exhibit 99.2 QUARTERLY SUPPLEMENTAL FIRST QUARTER 2023 FORWARD-LOOKING STATEMENTS COMPANY OVERVIEW Forward-looking statements involve known and unknown 3 risks, uncertainties and other factors that may cause the actual results of the Company or future events to differ Company Information 3 materially from those expressed in or underlying such forward-looking statements, including without l |
|
| April 27, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confid |
|
| April 10, 2023 |
MEDICAL PROPERTIES TRUST RESPONDS TO WALL STREET JOURNAL ARTICLE EX-99.1 Exhibit 99.1 Contact: Drew Babin, CFA, CMA Senior Managing Director – Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST RESPONDS TO WALL STREET JOURNAL ARTICLE Birmingham, AL – April 7, 2023 – Medical Properties Trust, Inc. (the “Company” or “MPT”) (NYSE: MPW) today issued a statement to address content of a Wa |
|
| April 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 7, 2023 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of in |
|
| March 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 30, 2023 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of i |
|
| March 31, 2023 |
EX-99.1 Exhibit 99.1 Contact: Drew Babin, CFA, CMA Senior Managing Director – Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST FILES LAWSUIT AGAINST SHORT-SELLER VICEROY RESEARCH AND ITS MEMBERS, SENDS LETTER TO SHAREHOLDERS Viceroy’s Numerous Defamatory, False and Misleading Claims Have Caused Serious Harm to MPT and |
|
| March 24, 2023 |
March 24, 2023 VIA EDGAR United States Securities and Exchange Commission Division of Corporate Finance Office of Real Estate and Construction 100 F Street, NE Washington, D. |
|
| March 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file |
|
| March 1, 2023 |
Subsidiaries of Medical Properties Trust, Inc. Exhibit 21.1 SUBSIDIARIES OF REGISTRANT Subsidiaries Jurisdiction of Organization Jurisdiction(s) in Which Qualified as a Foreign Corporation Medical Properties Trust, LLC Delaware Alabama, Massachusetts Mountain View-MPT Hospital, LLC Delaware Idaho MPT of Altoona, LLC Delaware Wisconsin MPT of Alvarado, LLC Delaware California MPT of Alvarado, L.P. Delaware California MPT of Alvin FCER, LLC Dela |
|
| February 27, 2023 |
Fourth Quarter 2022 Supplemental Update FEBRUARY 2023 EX-99.1 Exhibit 99.1 Fourth Quarter 2022 Supplemental Update FEBRUARY 2023 FORWARD-LOOKING STATEMENTS This presentation includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements can generally be identified by the use of forward-looking words such as |
|
| February 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 27, 2023 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Maryland 001-32559 20-0191742 (State or other jurisdiction of incorporation or orga |
|
| February 23, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 16, 2023 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction o |
|
| February 23, 2023 |
EX-99.1 Exhibit 99.1 Contact: Drew Babin, CFA, CMA Senior Managing Director of Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST, INC. REPORTS FOURTH QUARTER AND FULL-YEAR RESULTS Per Share Net Loss of ($0.24) and Normalized FFO of $0.43 in Fourth Quarter 35% Growth in Net Income and 4% Growth in Both NFFO and AFFO, on |
|
| February 23, 2023 |
EX-99.2 Exhibit 99.2 Q4 2022SUPPLEMENTAL COMPANY OVERVIEWCompany Information 3FINANCIAL INFORMATIONReconciliation of Net Income to Funds from Operations 6Debt Summary 7Adjusted Net Debt / Annualized EBITDAre 8PORTFOLIO INFORMATIONAdjusted Lease and Loan Maturity Schedule 9Total Assets and Revenuesby Asset Type, Operator, State and Country 10Rent Coverage 13Summary of Investments and Development Pr |
|
| February 23, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 23, 2023 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction o |
|
| February 23, 2023 |
EX-99.1 Exhibit 99.1 Contact: Drew Babin, CFA, CMA Senior Managing Director of Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] CO-FOUNDER EMMETT E. MCLEAN TO RETIRE AS MEDICAL PROPERTIES TRUST EXECUTIVE VICE PRESIDENT, CHIEF OPERATING OFFICER AND SECRETARY Birmingham, AL – February 23, 2023 – Medical Properties Trust, Inc. (the “Company” or |
|
| February 9, 2023 |
MPW / Medical Properties Trust, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 17)* Name of issuer: Medical Properties Trust Inc. Title of Class of Securities: REIT CUSIP Number: 58463J304 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule pursuant to which this Schedule is filed |
|
| February 8, 2023 |
February 8, 2023 VIA EDGAR United States Securities and Exchange Commission Division of Corporate Finance Office of Real Estate and Construction 100 F Street, NE Washington, D. |
|
| November 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file n |
|
| November 2, 2022 |
November 2, 2022 VIA EDGAR United States Securities and Exchange Commission Division of Corporate Finance Office of Real Estate and Construction 100 F Street, NE Washington, D. |
|
| October 27, 2022 |
Exhibit 99.1 Contact: Drew Babin, CFA, CMA Senior Managing Director of Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST, INC. REPORTS THIRD QUARTER RESULTS Per Share Net Income of $0.37 and Normalized FFO of $0.45 in Third Quarter Year-to-Date Capital Recycling Transactions Generate Approximately $1.8 Billion of Cash |
|
| October 27, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 27, 2022 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of |
|
| October 27, 2022 |
MEDICAL PROPERTIES TRUST Q3 2022 SUPPLEMENTAL Exhibit 99.2 MEDICAL PROPERTIES TRUST Q3 2022 SUPPLEMENTAL COMPANY OVERVIEW Company Information 3 FINANCIAL INFORMATION Reconciliation of Net Income to Funds from Operations 6 Debt Summary 7 Adjusted Net Debt / Annualized EBITDAre 8 PORTFOLIO INFORMATION Adjusted Lease and Loan Maturity Schedule 9 Total Adjusted Gross Assets and Adjusted Revenues by Asset Type, Operator, State and Country 10 Rent |
|
| October 11, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 11, 2022 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of |
|
| October 11, 2022 |
MEDICAL PROPERTIES TRUST ANNOUNCES AUTHORIZATION OF STOCK REPURCHASE PROGRAM Exhibit 99.1 Contact: Drew Babin, CFA, CMA Senior Managing Director ? Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST ANNOUNCES AUTHORIZATION OF STOCK REPURCHASE PROGRAM Birmingham, AL ? October 10, 2022 ? Medical Properties Trust, Inc. (the ?Company? or ?MPT?) (NYSE: MPW) today announced that its Board of Directors |
|
| September 28, 2022 |
September 28, 2022 VIA EDGAR United States Securities and Exchange Commission Division of Corporate Finance Office of Real Estate and Construction 100 F Street, NE Washington, D. |
|
| August 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file number |
|
| August 8, 2022 |
Exhibit 107 Calculation of Filing Fee Table FORM S-8 (Form Type) MEDICAL PROPERTIES TRUST, INC. |
|
| August 8, 2022 |
As filed with the Securities and Exchange Commission on August 8, 2022 As filed with the Securities and Exchange Commission on August 8, 2022 File No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MEDICAL PROPERTIES TRUST, INC. (Exact name of registrant as specified in its charter) Maryland 20-0191742 (State or other jurisdiction of incorporation or organization) (I.R.S. E |
|
| August 3, 2022 |
Pictured: Morton Hospital Investor Update AUGUST 2022 Exhibit 99.3 Pictured: Morton Hospital Investor Update AUGUST 2022 AT THE VERY HEART OF HEALTH CARE.® FORWARD-LOOKING STATEMENTS This presentation includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements can generally be identified by the use of for |
|
| August 3, 2022 |
Exhibit 99.1 Contact: Drew Babin, CFA, CMA Senior Managing Director of Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST, INC. REPORTS SECOND QUARTER RESULTS Per Share Net Income of $0.32 and Normalized FFO of $0.46 in Second Quarter 7% Growth in Per Share NFFO Versus Prior-Year Quarter Expansion of Spain Footprint Inc |
|
| August 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 3, 2022 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of i |
|
| August 3, 2022 |
Medical properties trustQ2 2022 Supplemental Exhibit 99.2 Medical properties trustQ2 2022 Supplemental 3 COMPANY OVERVIEW Company Information 3 FINANCIAL INFORMATION Reconciliation of Net Income to Funds from Operations 6 6 Debt Summary 7 Pro Forma Net Debt / Annualized Adjusted EBITDAre 8 PORTFOLIO INFORMATION Pro Forma Lease and Loan Maturity Schedule 9 9 Total Pro Forma Gross Assets and Adjusted Revenue by Asset Type, Operator, State and |
|
| July 6, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 29, 2022 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Maryland Delaware 001-32559 333-177186 20-0191742 20-02 |
|
| July 6, 2022 |
EX-1.1 2 d379139dex11.htm EX-1.1 Exhibit 1.1 Execution Version SECOND AMENDED AND RESTATED REVOLVING CREDIT AND TERM LOAN AGREEMENT among MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P., as Borrower, The Several Lenders from Time to Time Parties Hereto, JPMORGAN CHASE BANK, N.A., as Administrative Agent BANK OF AMERICA, N.A., as Syndication Agent BARCLAYS BANK PLC, GOLDMAN SACHS BAN |
|
| May 27, 2022 |
Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 26, 2022 Medical Properties Trust, Inc. (Exact name of Registrant as Specified in Its Charter) Maryland 001-32559 20-0191742 (State or Other Jurisdiction of Incorporation) (Commis |
|
| May 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file numbe |
|
| April 28, 2022 |
Exhibit 99.2 Q1 2022 SUPPLEMENTAL FORWARD-LOOKING STATEMENTS COMPANY OVERVIEW Forward-looking statements involve known and 3 unknown risks, uncertainties and other factors that Company Information 3 may cause the actual results of the Company or future events to differ materially from those expressed in or underlying such forward-looking statements, including without limitation: Normalized FFO per |
|
| April 28, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confid |
|
| April 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of |
|
| April 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 28, 2022 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of i |
|
| April 28, 2022 |
Exhibit 99.1 Contact: Drew Babin, CFA, CMA Senior Managing Director of Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST, INC. REPORTS FIRST QUARTER RESULTS Per Share Net Income of $1.05 and Normalized FFO of $0.47 in First Quarter 12% Growth in Per Share NFFO Versus Prior-Year Quarter Acquisitions, Dispositions and Ma |
|
| April 28, 2022 |
® AT THE VERY HEART OF HEALTHCARE. Exhibit 99.3 HM Torrelodones ? Madrid, Spain INVESTOR UPDATE APRIL 2022 ? AT THE VERY HEART OF HEALTHCARE. FORWARD-LOOKING STATEMENTS This presentation includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements can generally be identified by the use o |
|
| March 18, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 16, 2022 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Commission File Numbe |
|
| March 18, 2022 |
Exhibit 99.1 Contact: Drew Babin, CFA, CMA Senior Managing Director ? Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST COMPLETES HOSPITAL PARTNERSHIP WITH MACQUARIE ASSET MANAGEMENT $1.7 Billion Valuation and 47% Gain on Sale of Real Estate Point to Embedded Value in MPT?s Portfolio $1.3 Billion in Cash Proceeds to MP |
|
| March 1, 2022 |
Subsidiaries of Medical Properties Trust, Inc. EX-21.1 3 mpw-ex2117.htm EX-21.1 Exhibit 21.1 SUBSIDIARIES OF REGISTRANT Subsidiaries Jurisdiction of Organization Jurisdiction(s) in Which Qualified as a Foreign Corporation Medical Properties Trust, LLC Delaware Alabama, Massachusetts Mountain View-MPT Hospital, LLC Delaware Idaho MPT of Allen FCER, LLC Delaware Texas MPT of Altoona, LLC Delaware Wisconsin MPT of Alvarado, LLC Delaware Californi |
|
| March 1, 2022 |
Exhibit 10.30 AMENDMENT NO. 2 TO AMENDED AND RESTATED REVOLVING CREDIT AND TERM LOAN AGREEMENT This AMENDMENT NO. 2 TO AMENDED AND RESTATED REVOLVING CREDIT AND TERM LOAN AGREEMENT, dated as of November 22, 2021 (this ?Amendment No. 2?), is by and among MEDICAL PROPERTIES TRUST, INC., a Maryland corporation (?Holdings?), MPT OPERATING PARTNERSHIP, L.P., a Delaware limited partnership (the ?Borrowe |
|
| March 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ?ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ?TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file n |
|
| February 23, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 17, 2022 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction o |
|
| February 23, 2022 |
EMILY W. MURPHY APPOINTED TO THE BOARD OF DIRECTORS OF MEDICAL PROPERTIES TRUST Exhibit 99.1 Contact: Drew Babin, CFA, CMA Senior Managing Director of Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] EMILY W. MURPHY APPOINTED TO THE BOARD OF DIRECTORS OF MEDICAL PROPERTIES TRUST Birmingham, AL ? February 23, 2022 ? Medical Properties Trust, Inc. (the ?Company? or ?MPT?) (NYSE: MPW) today announced the appointment of Emil |
|
| February 14, 2022 |
MPW / Medical Properties Trust, Inc. / COHEN & STEERS, INC. Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2 (Exit Filing)* Medical Properties Trust Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 58463J304 (CUSIP Number) December 31, 2021 (Date of Event Which Req |
|
| February 10, 2022 |
MPW / Medical Properties Trust, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 16)* Name of issuer: Medical Properties Trust Inc. Title of Class of Securities: REIT CUSIP Number: 58463J304 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed |
|
| February 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Medical Properties Trust, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 58463J304 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to wh |
|
| February 3, 2022 |
MPT Medical Properties Trust SUPPLEMENTAL Q4 Exhibit 99.2 MPT Medical Properties Trust SUPPLEMENTAL Q4 3 (COMPANY)OVERVIEW Company Information 3 FINANCIAL INFORMATION Reconciliation of Net Income to Funds from Operations 6 6 Debt Summary 7 Debt Maturity Schedule 8 Pro Forma Net Debt /Annualized Adjusted EBITDA 9 PORTFOLIO INFORMATION Pro Forma Lease and Loan Maturity Schedule 10 10 (Total)Pro Forma Gross Assets and Adjusted Revenue by Asset |
|
| February 3, 2022 |
Exhibit 99.1 Contact: Drew Babin, CFA, CMA Senior Managing Director of Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST, INC. REPORTS FOURTH QUARTER AND FULL-YEAR RESULTS Per Share Net Income of $0.34 and Normalized FFO of $0.47 in Fourth Quarter Robust Double-Digit Growth in Full-Year Net Income, NFFO and AFFO per Sh |
|
| February 3, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 3, 2022 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of |
|
| January 3, 2022 |
Statement of Eligibility on Form T-1 Exhibit 25.1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 ? Check if an Application to Determine Eligibility of a Trustee Pursuant to Section 305(b)(2) WILMINGTON TRUST, NATIONAL ASSOCIATION (Exact name of trustee as specified in its charter) 16-1486454 (I.R.S. employer identification no.) 1100 North Market Street Wilmington, DE 19890-0001 (Address of principal |
|
| January 3, 2022 |
As filed with the Securities and Exchange Commission on December 30, 2021 Table of Contents As filed with the Securities and Exchange Commission on December 30, 2021 Registration No. |
|
| November 9, 2021 |
EX-10.2 3 mpw-ex102106.htm EX-10.2 Exhibit 10.2 AMENDMENT NO. 1 TO AMENDED AND RESTATED REVOLVING CREDIT AND TERM LOAN AGREEMENT This AMENDMENT NO. 1 TO AMENDED AND RESTATED REVOLVING CREDIT AND TERM LOAN AGREEMENT, dated as of September 29, 2021 (this “Amendment No. 1”), is by and among MEDICAL PROPERTIES TRUST, INC., a Maryland corporation (“Holdings”), MPT OPERATING PARTNERSHIP, L.P., a Delawar |
|
| November 9, 2021 |
EXHIBIT 10.1 AMENDED AND RESTATED MASTER LEASE AGREEMENT BY AND AMONG THE ENTITIES LISTED ON SCHEDULE 1-A ATTACHED HERETO, (collectively, jointly and severally, ?Lessor?) AND THE ENTITIES LISTED ON SCHEDULE 1-B ATTACHED HERETO, (collectively, jointly and severally, as ?Lessee?) August 27, 2021 4834-1440-2281v12 Table of Contents Page ARTICLE I. DEFINITIONS 3 1.1. Certain Defined Terms 3 1.2. Inter |
|
| November 9, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file n |
|
| October 28, 2021 |
Medical Properties Trust SUPPLEMENTAL Q3 Exhibit 99.2 Medical Properties Trust SUPPLEMENTAL Q3 3 COMPANY OVERVIEW Company Information 3 FINANCIAL INFORMATION Reconciliation of Net Income to Funds from Operations 6 6 Debt Summary 7 Debt Maturity Schedule 8 Pro Forma Net Debt /Annualized Adjusted EBITDA 9 PORTFOLIO INFORMATION Pro Forma Lease and Loan Maturity Schedule 10 10 Total Pro Forma Gross Assets and Adjusted Revenue by Asset Type, |
|
| October 28, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 28, 2021 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of |
|
| October 28, 2021 |
EX-99.1 2 d403434dex991.htm EX-99.1 Exhibit 99.1 Contact: Drew Babin, CFA Senior Managing Director of Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST, INC. REPORTS THIRD QUARTER RESULTS Per Share Net Income of $0.29 and Normalized FFO of $0.44 in Third Quarter Double-Digit Per Share NFFO and AFFO Growth Year-to-Date |
|
| October 13, 2021 |
Exhibit 4.2 Execution Version MPT OPERATING PARTNERSHIP, L.P. and MPT FINANCE CORPORATION, as Issuers, MEDICAL PROPERTIES TRUST, INC., as Parent and a Guarantor WILMINGTON TRUST, NATIONAL ASSOCIATION, as Trustee and ELAVON FINANCIAL SERVICES DAC, as Paying Agent, Registrar and Transfer Agent 0.993% Senior Notes due 2026 NINETEENTH SUPPLEMENTAL INDENTURE Dated as of October 6, 2021 CROSS-REFERENCE |
|
| October 13, 2021 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 6, 2021 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Maryland Delaware 001-32559 333-177186 20-0191742 20- |
|
| September 28, 2021 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 22, 2021 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Maryland Delaware 001-32559 333-177186 20-0191742 |
|
| September 28, 2021 |
Exhibit 1.1 ?500,000,000 MPT OPERATING PARTNERSHIP, L.P. MPT FINANCE CORPORATION 0.993% Senior Notes due 2026 UNDERWRITING AGREEMENT September 22, 2021 Barclays Bank PLC 5 The North Colonnade Canary Wharf London E14 4BB United Kingdom Goldman Sachs & Co. LLC 200 West Street New York, New York 10282 J.P. Morgan Securities plc 25 Bank Street Canary Wharf London E14 5JP United Kingdom Merrill Lynch I |
|
| September 24, 2021 |
Table of Contents Filed Pursuant to Rule 424(b)(2) Registration Nos. 333-229103, 333-229103-01 and 333-229103-02 CALCULATION OF REGISTRATION FEE Title of Each Class of Securities to be Registered Amount to be Registered(1) Maximum Offering Price Per Unit Maximum Aggregate Offering Price(1) Amount of Registration Fee 0.993% Senior Notes due 2026 $584,350,000 100.000% $584,350,000 $63,752.59(2) Guar |
|
| September 22, 2021 |
Issuer Free Writing Prospectus filed pursuant to Rule 433 supplementing the Preliminary Prospectus Supplement dated September 22, 2021 Registration Nos. |
|
| September 22, 2021 |
Subject to Completion, dated September 22, 2021 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration Nos. 333-229103, 333-229103-01 and 333-229103-02 The information in this preliminary prospectus supplement is not complete and may be changed. A registration statement relating to the securities has become effective under the Securities Act of 1933, as amended. This preliminary prospectus supplement and the accompanying prospectus do |
|
| September 1, 2021 |
Exhibit 99.1 Contact: Drew Babin, CFA Senior Managing Director ? Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST AND MACQUARIE INFRASTRUCTURE PARTNERS V ENTER PARTNERSHIP FOR EIGHT MASSACHUSETTS HOSPITALS VALUED AT $1.78 BILLION Expected Cash Proceeds to MPT of $1.3 Billion to Repay Debt and Fund Previously Announced |
|
| September 1, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 1, 2021 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Commission File Nu |
|
| August 9, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file number |
|
| July 29, 2021 |
Medical Properties Trust Q2 SUPPLEMENTAL 2021 Exhibit 99.2 Medical Properties Trust Q2 SUPPLEMENTAL 2021 3 COMPANY OVERVIEW Company Information 3 FINANCIAL INFORMATION Reconciliation of Net Income to Funds from Operations 6 6 Debt Summary 7 Debt Maturity Schedule 8 Pro Forma Net Debt /Annualized Adjusted EBITDA 9 PORTFOLIO INFORMATION Lease and Loan Maturity Schedule 10 10 Total Pro Forma Gross Assets and Adjusted Revenue by Asset Type, Opera |
|
| July 29, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 29, 2021 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of in |
|
| July 29, 2021 |
Exhibit 99.1 Contact: Drew Babin, CFA Senior Managing Director ? Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST, INC. REPORTS SECOND QUARTER RESULTS Per Share Net Income of $0.19 and Normalized FFO of $0.43 in Second Quarter Per Share NFFO and AFFO Growth Exceeding 13% Compared to Prior-Year Quarter Year-to-Date Inv |
|
| June 9, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) ?ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ?TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-325 |
|
| June 9, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 9, 2021 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Maryland 001-32559 20-0191742 (State or other jurisdiction of incorporation or organizat |
|
| June 9, 2021 |
Consolidated Financial Statements of Steward Health Care System LLC as of December 31, 2020 and 2019 Exhibit 99.1 Steward Health Care System LLC Consolidated Financial Statements Years Ended December 31, 2020 and 2019 (With Independent Auditors? Report Thereon) Steward Health Care System LLC Consolidated Financial Statements Years ended December 31, 2020 and 2019 Contents Page Independent Auditors? Report 1 Consolidated Balance Sheets 5 Consolidated Statements of Operations 6 Consolidated Stateme |
|
| June 9, 2021 |
® AT THE VERY HEART OF HEALTHCARE.® AT THE VERY HEART OF HEALTHCARE. Exhibit 99.1 Reading Hospital near London, UK REITweek: 2021 Investor Conference JUNE 2021Exhibit 99.1 Reading Hospital near London, UK REITweek: 2021 Investor Conference JUNE 2021 ? AT THE VERY HEART OF HEALTHCARE.? AT THE VERY HEART OF HEALTHCARE. FORWARD-LOOKING STATEMENTS This presentation includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as a |
|
| May 28, 2021 |
Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 26, 2021 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Maryland 001-32559 20-0191742 (State or other jurisdiction of incorporation or organizat |
|
| May 10, 2021 |
Execution Version Exhibit 10.1 AMENDED AND RESTATED REVOLVING CREDIT AND TERM LOAN AGREEMENT among MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P., as Borrower, The Several Lenders from Time to Time Parties Hereto, JPMORGAN CHASE BANK, N.A., as Administrative Agent BANK OF AMERICA, N.A., as Syndication Agent BARCLAYS BANK PLC, GOLDMAN SACHS BANK USA, KEYBANK NATIONAL ASSOCIATION, CI |
|
| May 10, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file numbe |
|
| April 29, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 29, 2021 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of i |
|
| April 29, 2021 |
Exhibit 99.2 Q SUPPLEMENTAL 1 2021 3 COMPANY OVERVIEW Company Information 3 FINANCIAL INFORMATION Reconciliation of Net Income to Funds from Operations 6 6 Debt Summary 7 Debt Maturity Schedule 8 Pro Forma Net Debt /Annualized Adjusted EBITDA 9 PORTFOLIO INFORMATION Lease and Loan Maturity Schedule 10 10 Total Pro Forma Gross Assets and Adjusted Revenue by Asset Type, Operator, State and Country 1 |
|
| April 29, 2021 |
Exhibit 99.1 Contact: Drew Babin, CFA Senior Managing Director ? Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST, INC. REPORTS FIRST QUARTER RESULTS Per Share Net Income of $0.28 and Normalized FFO of $0.42 in First Quarter Per Share NFFO Growth Exceeding 13% Compared to Prior-Year Quarter Year-to-Date Investments of |
|
| April 26, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (RULE 14A-101) PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definit |
|
| April 26, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (RULE 14A-101) PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definit |
|
| March 29, 2021 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 24, 2021 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Maryland Delaware 001-32559 333-177186 20-0191742 20-0 |
|
| March 29, 2021 |
Exhibit 4.2 Execution Version MPT OPERATING PARTNERSHIP, L.P. and MPT FINANCE CORPORATION, as Issuers, MEDICAL PROPERTIES TRUST, INC., as Parent and a Guarantor WILMINGTON TRUST, NATIONAL ASSOCIATION, as Trustee and ELAVON FINANCIAL SERVICES DAC, as Paying Agent, Registrar and Transfer agent 2.500% Senior Notes due 2026 SEVENTEENTH SUPPLEMENTAL INDENTURE Dated as of March 24, 2021 CROSS-REFERENCE |
|
| March 29, 2021 |
Exhibit 4.4 Execution Version MPT OPERATING PARTNERSHIP, L.P. and MPT FINANCE CORPORATION, as Issuers, MEDICAL PROPERTIES TRUST, INC., as Parent and a Guarantor WILMINGTON TRUST, NATIONAL ASSOCIATION, as Trustee and ELAVON FINANCIAL SERVICES DAC, as Paying Agent, Registrar and Transfer agent 3.375% Senior Notes due 2030 EIGHTEENTH SUPPLEMENTAL INDENTURE Dated as of March 24, 2021 CROSS-REFERENCE T |
|
| March 22, 2021 |
Exhibit 1.1 UNDERWRITING AGREEMENT MPT OPERATING PARTNERSHIP, L.P. MPT FINANCE CORPORATION ?500 million 2.500% Senior Notes due 2026 ?350 million 3.375% Senior Notes due 2030 March 17, 2021 Goldman Sachs & Co. LLC 200 West Street New York, New York 10282 Barclays Bank PLC 5 The North Colonnade Canary Wharf London E14 4BB United Kingdom J.P. Morgan Securities plc 25 Bank Street Canary Wharf London |
|
| March 22, 2021 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 17, 2021 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Maryland Delaware 001-32559 333-177186 20-0191742 20-0 |
|
| March 19, 2021 |
Table of Contents Filed Pursuant to Rule 424(b)(2) Registration Nos. 333-229103, 333-229103-01 and 333-229103-02 CALCULATION OF REGISTRATION FEE Title of Each Class of Securities to be Registered Amount to be Registered(1) Maximum Offering Price Per Unit Maximum Aggregate Offering Price(1) Amount of Registration Fee 2.500% Senior Notes due 2026 $698,300,000 99.937% $697,860,071.00 $76,136.54(2) 3. |
|
| March 17, 2021 |
Issuer Free Writing Prospectus filed pursuant to Rule 433 supplementing the Preliminary Prospectus Supplement dated March 17, 2021 Registration Nos. |
|
| March 17, 2021 |
Subject to Completion, dated March 17, 2021 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration Nos. 333-229103, 333-229103-01 and 333-229103-02 The information in this preliminary prospectus supplement is not complete and may be changed. A registration statement relating to the securities has become effective under the Securities Act of 1933, as amended. This preliminary prospectus supplement and the accompanying prospectus do |
|
| March 1, 2021 |
Subsidiaries of Medical Properties Trust, Inc. Exhibit 21.1 SUBSIDIARIES OF REGISTRANT Subsidiaries Jurisdiction of Organization Jurisdiction(s) in Which Qualified as a Foreign Corporation Medical Properties Trust, LLC Delaware Alabama, Massachusetts Mountain View-MPT Hospital, LLC Delaware Idaho MPT of Allen FCER, LLC Delaware Texas MPT of Altoona, LLC Delaware Wisconsin MPT of Alvarado, LLC Delaware California MPT of Alvarado, L.P. Delaware |
|
| March 1, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ?ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ?TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file n |
|
| February 10, 2021 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 15)* Name of issuer: Medical Properties Trust Inc. Title of Class of Securities: REIT CUSIP Number: 58463J304 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is filed |
|
| February 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Medical Properties Trust, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 58463J304 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to whic |
|
| February 4, 2021 |
EX-99.2 Exhibit 99.2 4 Q Supplemental 2020 3 COMPANY OVERVIEW Company Information 3 FINANCIAL INFORMATION Reconciliation of Net Income to Funds from Operations 6 6 Debt Summary 7 Debt Maturity Schedule 8 Pro Forma Net Debt /Annualized Adjusted EBITDA 9 PORTFOLIO INFORMATION Lease and Loan Maturity Schedule 10 10 Total Pro Forma Gross Assets and Adjusted Revenue by Asset Type, Operator, State and C |
|
| February 4, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 4, 2021 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of |
|
| February 4, 2021 |
EX-99.1 Exhibit 99.1 Contact: Drew Babin, CFA Senior Managing Director – Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST, INC. REPORTS FOURTH QUARTER AND FULL-YEAR RESULTS Per Share Net Income of $0.20 and Normalized FFO of $0.41 in Fourth Quarter Full-Year Growth in NFFO per Share of Approximately 21% Nearly $3.6 Bi |
|
| January 22, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 15, 2021 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Maryland Delaware 001-32559 333-177186 20-0191742 20 |
|
| January 11, 2021 |
EX-1.1 Exhibit 1.1 UNDERWRITING AGREEMENT MEDICAL PROPERTIES TRUST, INC. 32,000,000 shares of common stock, par value $0.001 per share January 6, 2021 Goldman Sachs & Co. LLC 200 West Street New York, New York 10282 BofA Securities, Inc. One Bryant Park New York, New York 10036 J.P. Morgan Securities LLC 383 Madison Avenue New York, New York 10179 As Representatives of the several Underwriters lis |
|
| January 11, 2021 |
Financial Statements and Exhibits, Other Events - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 6, 2021 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in its Charter) Maryland 001-32559 20-0191742 (State or other jurisdiction of incorporation) (Com |
|
| January 8, 2021 |
424B2 Table of Contents Filed Pursuant to Rule 424(b)(2) Registration No. 333-229103 CALCULATION OF REGISTRATION FEE Title of Each Class of Securities to be Registered Amount to be Registered Proposed Maximum Offering Price per Share Proposed Maximum Aggregate Offering Price Amount of Registration Fee(1) Common Stock, par value $0.001 per share 36,800,000 $20.05 $737,840,000 $80,498.34 (1) The fil |
|
| January 7, 2021 |
EX-99.1 Exhibit 99.1 Contact: Drew Babin, CFA Senior Managing Director – Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST TO ACQUIRE £800 MILLION IN BEHAVIORAL HOSPITALS MPT to Own Critical Real Estate of Europe’s New Dominant Comprehensive Rehabilitation Provider Solidifies MPT’s Leading Position in UK Healthcare Rea |
|
| January 7, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 6, 2021 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in its Charter) Maryland 001-32559 20-0191742 Delaware 333-177186 |
|
| January 6, 2021 |
Subject to Completion, dated January 6, 2021 Form 424(b)(5) Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. |
|
| December 7, 2020 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 4, 2020 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Maryland Delaware 001-32559 333-177186 20-0191742 20 |
|
| December 7, 2020 |
EX-4.2 Exhibit 4.2 Execution Version MPT OPERATING PARTNERSHIP, L.P. and MPT FINANCE CORPORATION, as Issuers, MEDICAL PROPERTIES TRUST, INC., as Parent and a Guarantor, and WILMINGTON TRUST, NATIONAL ASSOCIATION, as Trustee 3.500% Senior Notes due 2031 SIXTEENTH SUPPLEMENTAL INDENTURE Dated as of December 4, 2020 CROSS-REFERENCE TABLE* Trust Indenture Act Section Indenture Section 310(a)(1) 8.10 ( |
|
| November 24, 2020 |
Financial Statements and Exhibits, Other Events - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 19, 2020 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Maryland Delaware 001-32559 333-177186 20-0191742 2 |
|
| November 24, 2020 |
EX-1.1 Exhibit 1.1 UNDERWRITING AGREEMENT $1,300,000,000 MPT OPERATING PARTNERSHIP, L.P. MPT FINANCE CORPORATION 3.500% Senior Notes due 2031 November 19, 2020 Goldman Sachs & Co. LLC 200 West Street New York, New York 10282 Credit Agricole Securities (USA) Inc. 1301 Avenue of the Americas, 13th Floor New York, New York 10019 Wells Fargo Securities, LLC 550 South Tryon Street, 5th Floor Charlotte, |
|
| November 23, 2020 |
424B2 Table of Contents Filed Pursuant to Rule 424(b)(2) Registration Nos. 333-229103, 333-229103-01 and 333-229103-02 CALCULATION OF REGISTRATION FEE Title of Each Class of Securities to be Registered Amount to be Registered Proposed Maximum Offering Price Per Unit Proposed Maximum Aggregate Offering Price Amount of Registration Fee 3.500% Senior Notes due 2031 $1,300,000,000 100% $1,300,000,000 |
|
| November 20, 2020 |
FWP Issuer Free Writing Prospectus filed pursuant to Rule 433 supplementing the Preliminary Prospectus Supplement dated November 19, 2020 Registration Nos. |
|
| November 19, 2020 |
Subject to Completion, dated November 19, 2020 424B5 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration Nos. 333-229103, 333-229103-01 and 333-229103-02 The information in this preliminary prospectus supplement is not complete and may be changed. A registration statement relating to the securities has become effective under the Securities Act of 1933, as amended. This preliminary prospectus supplement and the accompanying prospect |
|
| November 9, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file n |
|
| October 29, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 29, 2020 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of |
|
| October 29, 2020 |
EX-99.1 Exhibit 99.1 Contact: Drew Babin, CFA Senior Managing Director – Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST, INC. REPORTS THIRD QUARTER RESULTS Per Share Net Income of $0.25 and Normalized FFO of $0.41 Approximately 25% Year-over-Year Growth in Net Income and NFFO per Share Nearly $2.9 Billion of Investm |
|
| October 29, 2020 |
EX-99.2 Exhibit 99.2 Medical Properties Trust 3 COMPANY OVERVIEW Company Information 3 FINANCIAL INFORMATION Reconciliation of Net Income to Funds from Operations 6 6 Debt Summary 7 Debt Maturity Schedule 8 Pro Forma Net Debt /Annualized Adjusted EBITDA 9 PORTFOLIO INFORMATION Lease and Loan Maturity Schedule 10 10 Total Pro Forma Gross Assets and Actual Revenue by Asset Type, Operator, State and |
|
| August 18, 2020 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 18, 2020 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Maryland 001-32559 20-0191742 (State or other jurisdiction of incorporation or organi |
|
| August 18, 2020 |
® AT THE VERY HEART OF HEALTHCARE® AT THE VERY HEART OF HEALTHCARE EX-99.1 Exhibit 99.1 MIZUHO NON-DEAL ROADSHOW AUGUST 2020Exhibit 99.1 MIZUHO NON-DEAL ROADSHOW AUGUST 2020 ® AT THE VERY HEART OF HEALTHCARE® AT THE VERY HEART OF HEALTHCARE FORWARD-LOOKING STATEMENTS This presentation includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. |
|
| August 10, 2020 |
Exhibit10.1 Lease [Name of MPT entity] and BMI Healthcare Limited and Circle Health Holdings Limited of land and buildings at [Property details] NOTE: This document is a conformed copy produced for information purposes only. The original lease dated 31 July 2006 and the deeds of variation to the lease dated 14 December 2018 or 3 June 2019 (as applicable) and 16 June 2020 should be referred to for |
|
| August 10, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file number |
|
| July 30, 2020 |
Supplemental Information SECOND QUARTER 2020 EX-99.2 Exhibit 99.2 Supplemental Information SECOND QUARTER 2020 COMPANY OVERVIEW Company Information 3 FINANCIAL INFORMATION Reconciliation of Net Income to Funds from Operations 5 Debt Summary 6 Debt Maturity Schedule 7 Pro Forma Net Debt /Annualized Adjusted EBITDA 8 PORTFOLIO INFORMATION Lease and Loan Maturity Schedule 9 Total Pro Forma Gross Assets and Actual Revenue by Asset Type, Operator |
|
| July 30, 2020 |
EX-99.1 2 d41231dex991.htm EX-99.1 Exhibit 99.1 Contact: Drew Babin, CFA Senior Managing Director – Corporate Communications Medical Properties Trust, Inc. (646) 884-9809 [email protected] MEDICAL PROPERTIES TRUST, INC. REPORTS SECOND QUARTER RESULTS Per Share Net Income of $0.21 and Normalized FFO of $0.38 $3.1 Billion of Closed and Announced Investments Year-to-Date 100% of Rent |
|
| July 30, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 30, 2020 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of in |
|
| May 22, 2020 |
Amendment to Second Amended and Restated Bylaws of Medical Properties Trust, Inc. EX-3.1 Exhibit 3.1 AMENDMENT TO THE SECOND AMENDED AND RESTATED BYLAWS OF MEDICAL PROPERTIES TRUST, INC. Article III, Section 3.01 of the Second Amended and Restated Bylaws of Medical Properties Trust, Inc. (the “Bylaws”) is hereby amended as follows: “SECTION 3.01. Enumeration. The officers of the Corporation shall consist of a President, a Chief Executive Officer, a Secretary and a Treasurer and |
|
| May 22, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 21, 2020 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Maryland 001-32559 20-0191742 (State or other jurisdiction of incorporation or organizat |
|
| May 11, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Commission file numbe |
|
| April 30, 2020 |
Medical Properties Trust Supplemental Information FIRST QUARTER 2020 EX-99.2 Exhibit 99.2 Medical Properties Trust Supplemental Information FIRST QUARTER 2020 COMPANY OVERVIEW Company Information 3 FINANCIAL INFORMATION Reconciliation of Net Income to Funds from Operations 5 Debt Summary 6 Debt Maturity Schedule 7 Pro Forma Net Debt /Annualized Adjusted EBITDA 8 PORTFOLIO INFORMATION Lease and Loan Maturity Schedule 9 Total Pro Forma Gross Assets and Actual Revenue |
|
| April 30, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 29, 2020 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction of i |
|
| April 30, 2020 |
EX-99.1 Exhibit 99.1 Contact: Tim Berryman Director – Investor Relations Medical Properties Trust, Inc. (205) 969-3755 [email protected] MEDICAL PROPERTIES TRUST, INC. REPORTS FIRST QUARTER RESULTS First Quarter Per Share Net Income of $0.15 and Normalized FFO of $0.37 Completes $2.0 Billion Circle/BMI Acquisition Marking the Largest Transaction in Company’s History; $1.8 Billio |
|
| April 24, 2020 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (RULE 14A-101) PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ |
|
| April 24, 2020 |
DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (RULE 14A-101) PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ |
|
| April 8, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 8, 2020 MEDICAL PROPERTIES TRUST, INC. MPT OPERATING PARTNERSHIP, L.P. (Exact Name of Registrant as Specified in Charter) Maryland Delaware 001-32559 333-177186 20-0191742 20-02 |
|
| March 23, 2020 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 23, 2020 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Maryland 001-32559 20-0191742 (State or other jurisdiction of incorporation or organiz |
|
| March 23, 2020 |
STATEMENT FROM OUR CEO ON THE COVID-19 PANDEMIC EX-99.1 Exhibit 99.1 STATEMENT FROM OUR CEO ON THE COVID-19 PANDEMIC The world has been hit with an unprecedented situation with the coronavirus (COVID-19) pandemic. Hospitals around the world are stepping up to the challenge and seeking to meet the urgent healthcare needs created by this pandemic. Medical Properties Trust owns hospitals in some of the hardest hit countries in Europe and, of cours |
|
| February 27, 2020 |
Subsidiaries of Medical Properties Trust, Inc. Exhibit 21.1 SUBSIDIARIES OF REGISTRANT Subsidiaries Jurisdiction of Organization Jurisdiction(s) in Which Qualified as a Foreign Corporation Medical Properties Trust, LLC Delaware Alabama, Massachusetts Mountain View-MPT Hospital, LLC Delaware Idaho MPT of Allen FCER, LLC Delaware Texas MPT of Altoona, LLC Delaware Wisconsin MPT of Alvarado, LLC Delaware California MPT of Alvarado, L.P. Delaware |
|
| February 27, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 or ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32559 Medical Propertie |
|
| February 27, 2020 |
Exhibit 4.2 Description of Securities of Medical Properties Trust, Inc. Registered under Section 12 of the Securities Exchange Act of 1934, as Amended The following is a summary of the material terms of the shares of common stock, par value $0.001 per share (“Common Stock”), of Medical Properties Trust, Inc., a Maryland corporation (the “Company”), as well as certain relevant provisions of the sec |
|
| February 27, 2020 |
Exhibit 99.1 Steward CONSOLIDATED FINANCIAL STATEMENTS Steward Health Care System LLC Years Ended December 31, 2018 and 2017 With Report of Independent Auditors Steward Health Care System LLC Consolidated Financial Statements Years Ended December 31, 2018 and 2017 Contents Report of Independent Auditors 1 Consolidated Balance Sheets 3 Consolidated Statements of Operations 4 Consolidated Statements |
|
| February 21, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 14, 2020 MEDICAL PROPERTIES TRUST, INC. (Exact Name of Registrant as Specified in Charter) Commission File Number 001-32559 Maryland 20-0191742 (State or other jurisdiction o |
|
| February 21, 2020 |
CATERINA A. MOZINGO ELECTED TO THE BOARD OF DIRECTORS OF MEDICAL PROPERTIES TRUST EX-99.1 Exhibit 99.1 Contact: Tim Berryman Director – Investor Relations Medical Properties Trust, Inc. (205) 969-3755 [email protected] CATERINA A. MOZINGO ELECTED TO THE BOARD OF DIRECTORS OF MEDICAL PROPERTIES TRUST Birmingham, AL – February 18, 2020 – Medical Properties Trust, Inc. (the “Company” or “MPT”) (NYSE: MPW) has announced the election of Caterina Ardon Mozingo, CPA |
|
| February 14, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3 )* MEDICAL PROPERTIES TRUST, INC. (Name of Issuer) Common Stock (Title of Class of Securities) 58463J304 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to wh |
|
| February 11, 2020 |
MPW / Medical Properties Trust Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 14)* Name of issuer: Medical Properties Trust Inc Title of Class of Securities: REIT CUSIP Number: 58463J304 Date of Event Which Requires Filing of this Statement: December 31, 2019 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |
